FdaApplication
NDA 208630
Identifiers
- fda_app_no: NDA208630
Properties
| Property | Value |
|---|---|
| applicant_name | NX DEVELOPMENT CORP |
| application_type | NDA |
| approval_date | 2017-06-06 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GLEOLAN | AMINOLEVULINIC ACID HYDROCHLORIDE | 1.5GM/VIAL | FOR SOLUTION;ORAL |
1 product